- Home
- ORGN vs CNTB Comparison
ORGN vs CNTB Comparison
Compare ORGN & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORGN | CNTB |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.4M | 128.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ORGN | CNTB |
|---|---|---|
| Price | $0.28 | $2.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | ★ 1.6M | 314.4K |
| Earning Date | 11-13-2025 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $25,122,000.00 | $762,000.00 |
| Revenue This Year | $49.18 | N/A |
| Revenue Next Year | $144.81 | $38,289.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.26 | $0.51 |
| 52 Week High | $1.36 | $3.28 |
Technical Indicators
Market Signals| Indicator | ORGN | CNTB |
|---|---|---|
| Relative Strength Index (RSI) | 20.87 | 48.07 |
| Support Level | $0.43 | $2.03 |
| Resistance Level | $0.46 | $2.38 |
| Average True Range (ATR) | 0.04 | 0.19 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 4.71 | 36.36 |
Price Performance
Historical ComparisonAbout ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.